Heparin-Induced Thrombocytopenia in 7MM Forecast to 2032: Emerging Therapies and Epidemiological Insights

DUBLIN, Aug. 17, 2023 /PRNewswire/ — The “Heparin-Induced Thrombocytopenia – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. Heparin-induced Thrombocytopenia remains a challenging immunological syndrome with potentially…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.